Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test

Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test

Abstract Background The Asia-Pacific Colorectal Screening (APCS) score is effective to screen high-risk groups of advanced colorectal neoplasia (ACN) patients but needs revising and can be combined with the fecal immunochemical test (FIT). This paper aimed to improve the APCS score and evaluate its...

Full description

Bibliographic Details
Main Authors:	Xu-xia He, Si-yi Yuan, Wen-bin Li, Hong Yang, Wen Ji, Zhi-qiang Wang, Jian-yu Hao, Chuan Chen, Wei-qing Chen, Ying-xin Gao, Ling-bo Li, Kai-liang Cheng, Jia-ming Qian, Li Wang, Jing-nan Li
Format:	Article
Language:	English
Published:	BMC 2019-12-01
Series:	BMC Gastroenterology
Subjects:	Colorectal cancer screening Advanced colorectal neoplasia Predictive model Fecal immunochemical test High risk population
Online Access:	https://doi.org/10.1186/s12876-019-1146-2

Similar Items

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
by: P. H. A. Wisse, et al.
Published: (2022-12-01)

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
by: Carrie M. Nielson, et al.
Published: (2018-09-01)

Positive fecal immunochemical test results are associated with non-colorectal cancer mortality
by: Yoon Suk Jung, et al.
Published: (2022-03-01)

Performance of the Fecal Immunochemical Test in Detecting Advanced Colorectal Neoplasms and Colorectal Cancers in People Aged 40–49 Years: A Systematic Review and Meta-Analysis
by: Jen-Hao Yeh, et al.
Published: (2023-05-01)

Interval Cancer Rate and Diagnostic Performance of Fecal Immunochemical Test According to Family History of Colorectal Cancer
by: Yoon Suk Jung, et al.
Published: (2020-10-01)

Risk of colorectal cancer in patients with positive results of fecal immunochemical test performed within 5 years since the last colonoscopy
by: Yoon Suk Jung, et al.
Published: (2021-09-01)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
by: Efrat L. Amitay, et al.
Published: (2019-03-01)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
by: Feiyuan Liu, et al.
Published: (2021-03-01)

Age, male sex, smoking and metabolic syndrome as risk factors of advanced colorectal neoplasia for fecal immunochemical test negative patients
by: Wei-Chun Cheng, et al.
Published: (2022-01-01)

Comparison between the Effectiveness Fecal Immunochemical Test and Colonoscopy As A Tool For Colorectal Cancer Early Detection
by: Yossi Andila, et al.
Published: (2022-03-01)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
by: Yinan Ren, et al.
Published: (2022-08-01)

Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
by: Brenner H, et al.
Published: (2018-04-01)

Performance of the fecal immunochemical test for colorectal cancer and advanced neoplasia in individuals under age 50
by: Emily Heer, et al.
Published: (2023-04-01)

Use of Antiplatelet Agents Decreases the Positive Predictive Value of Fecal Immunochemical Tests for Colorectal Cancer but Does Not Affect Their Sensitivity
by: Yoonsuk Jung, et al.
Published: (2021-06-01)

Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial
by: Elizabeth A. O’Connor, et al.
Published: (2020-01-01)

Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection
by: Hongli Xu, et al.
Published: (2022-08-01)

Factors Associated with the Use of Fecal Immunochemical Tests and Colonoscopy in the INSEF Portuguese Population
by: Fábio Sousa Gomes, et al.
Published: (2021-06-01)

Diagnostic Performance of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program According to Ambient Temperature and Humidity
by: Gemma Ibáñez-Sanz, et al.
Published: (2022-02-01)

Accuracy of a fecal immunochemical test according to outside temperature and travel time
by: Niedermaier T, et al.
Published: (2018-09-01)

Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)
by: Emilie C. H. Breekveldt, et al.
Published: (2023-02-01)

Diagnostic accuracy of risk assessment and fecal immunochemical test in colorectal cancer screening: Results from a population‐based program and meta‐analysis
by: Ziyang Wang, et al.
Published: (2023-09-01)

Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms
by: Tao Zeng, et al.
Published: (2023-08-01)

Polyprev: Randomized, Multicenter, Controlled Trial Comparing Fecal Immunochemical Test with Endoscopic Surveillance after Advanced Adenoma Resection in Colorectal Cancer Screening Programs: A Study Protocol
by: Cristina Regueiro, et al.
Published: (2021-08-01)

Evaluation of the Effectiveness of Colonoscopy, Fecal Immunochemical Test and Risk-adapted Screening Strategies in Population-based Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial
by: CHEN Hongda, et al.
Published: (2023-01-01)

Source matters: a survey of cost variation for fecal immunochemical tests in primary care
by: Jennifer Coury, et al.
Published: (2022-02-01)

Profiling small RNAs in fecal immunochemical tests: is it possible?
by: Einar Birkeland, et al.
Published: (2023-10-01)

Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study
by: Mingqing Zhang, et al.
Published: (2022-05-01)

Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis
by: Rachel B. Issaka, et al.
Published: (2022-08-01)

Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test
by: María Angeles Gutierrez-Stampa, et al.
Published: (2020-08-01)

An adjusted Asia-Pacific colorectal screening score system to predict advanced colorectal neoplasia in asymptomatic Chinese patients
by: Chenchen Zhang, et al.
Published: (2023-06-01)

Effects of Fecal Occult Blood Immunoassay Screening for Colorectal Cancer—Experience from a Hospital in Central Taiwan
by: Pei-Yu Yang, et al.
Published: (2023-03-01)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening
by: Ze Y, et al.
Published: (2023-03-01)

Clinical Effectiveness of Faecal Immunochemical Test in the Early Detection of Colorectal Cancer—An Umbrella Review
by: Jakub Świtalski, et al.
Published: (2022-09-01)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
by: Jun Kato, et al.
Published: (2016-01-01)

Effective strategies for Fecal Immunochemical Tests (FIT) programs to improve colorectal cancer screening uptake among populations with limited access to the healthcare system: a rapid review
by: Ana Paula Belon, et al.
Published: (2024-01-01)

Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population
by: Brenner H, et al.
Published: (2017-07-01)

Colorectal Cancer Screening Modalities in Chinese Population: Practice and Lessons in Pudong New Area of Shanghai, China
by: Wei-miao Wu, et al.
Published: (2019-06-01)

FIT-based risk-stratification model effectively screens colorectal neoplasia and early-onset colorectal cancer in Chinese population: a nationwide multicenter prospective study
by: Shengbing Zhao, et al.
Published: (2022-11-01)

Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
by: Dong-cheng Lu, et al.
Published: (2022-05-01)